-
公开(公告)号:US20230020217A1
公开(公告)日:2023-01-19
申请号:US17934268
申请日:2022-09-22
Applicant: AJINOMOTO CO., INC.
Inventor: Yu SUZUKI , Manabu KITAZAWA , Shimpei OGAWA
IPC: C12N5/074
Abstract: A cell proliferation rate can be improved by a medium for cell culture, containing 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) at a concentration of not less than 30 mM, and having an osmotic pressure of 220 to 340 mOsm/kg, and a cell culture method using the medium.
-
公开(公告)号:US20220348884A1
公开(公告)日:2022-11-03
申请号:US17863832
申请日:2022-07-13
Applicant: AJINOMOTO CO., INC.
Inventor: Shimpei OGAWA , Takuya HIGUCHI , Shumpei FUROMITSU , Yusuke OHYA , Megumi NISHIYAMA , Atsushi KONISHI
IPC: C12N5/074
Abstract: A medium with a reduced osmotic pressure containing a basal medium, in which the osmotic pressure is adjusted to 150 to 250 mOsm/kg, is useful for culturing cells.
-
公开(公告)号:US20220073882A1
公开(公告)日:2022-03-10
申请号:US17455763
申请日:2021-11-19
Applicant: AJINOMOTO CO., INC.
Inventor: Shimpei OGAWA , Mayumi TOKUYAMA
IPC: C12N5/077
Abstract: Culturing a cartilage or bone progenitor cell in a medium containing a TGF-β signal inhibitor and FGF is effective for expansion culture of a cartilage or bone progenitor cell, and inducing differentiation of a cartilage or bone progenitor cell obtained by such a method is effective for producing a chondrocyte or osteocyte.
-
公开(公告)号:US20230012723A1
公开(公告)日:2023-01-19
申请号:US17863646
申请日:2022-07-13
Applicant: AJINOMOTO CO., INC.
Inventor: Shimpei OGAWA , Takuya HIGUCHI , Shumpei FUROMITSU , Megumi NISHIYAMA , Kotoe KOSEKI
Abstract: Cells may be cultured by a method including the following steps: a first step of preparing a population of cell aggregates having a major axis of not more than 400 μm, and a second step of suspension culturing the population of cell aggregates obtained in the first step.
-
公开(公告)号:US20220348883A1
公开(公告)日:2022-11-03
申请号:US17863785
申请日:2022-07-13
Applicant: AJINOMOTO CO., INC.
Inventor: Shimpei OGAWA , Takuya HIGUCHI , Shumpei FUROMITSU , Megumi NISHIYAMA
IPC: C12N5/074 , C12N5/0735
Abstract: A method including adding choline at a specific concentration to a medium is useful for culturing cells.
-
公开(公告)号:US20250026799A1
公开(公告)日:2025-01-23
申请号:US18914383
申请日:2024-10-14
Applicant: AJINOMOTO CO., INC.
Inventor: Naoko TSUYOSHI , Teruhisa MANNEN , Yoshihiko MATSUDA , Shimpei OGAWA , Yasumichi KOSEKI , Tomomi KADO
Abstract: A method of producing cultured meat is provided. Cultured meat is produced by culturing animal cells in the presence of bovine basic fibroblast growth factor (bbFGF) produced by using a coryneform bacterium as an expression host.
-
公开(公告)号:US20230002729A1
公开(公告)日:2023-01-05
申请号:US17863546
申请日:2022-07-13
Applicant: AJINOMOTO CO., INC.
Inventor: Shimpei OGAWA , Takuya HIGUCHI , Shumpei FUROMITSU , Kenichiro ITO , Megumi NISHIYAMA
IPC: C12N5/0735
Abstract: A medium composition, containing a basic fibroblast growth factor (bFGF) at not less than 150 ng/mL is useful for culturing cells.
-
公开(公告)号:US20210284971A1
公开(公告)日:2021-09-16
申请号:US17213839
申请日:2021-03-26
Applicant: AJINOMOTO CO., INC.
Inventor: Takuya MATSUMOTO , Shimpei OGAWA , Shumpei FUROMITSU , Yusuke OHYA , Kotoe KOSEKI , Takuya HIGUCHI , Megumi NISHIYAMA
IPC: C12N5/074 , C12N5/0735
Abstract: By using an additive for culturing animal cells that contains an amino acid or glucose, or an amino acid and glucose; or a medium for culturing animal cells that contains an amino acid or glucose, or an amino acid and glucose in addition to a medium component; or a method for culturing animal cells that includes culturing the animal cells using the aforementioned medium, or adding the aforementioned additive to a culture, the proliferation ability of animal cells can be improved particularly when the animal cells are cultured using a serum-free medium or a low albumin medium.
-
公开(公告)号:US20170101372A1
公开(公告)日:2017-04-13
申请号:US15389639
申请日:2016-12-23
Applicant: AJINOMOTO CO., INC.
Inventor: Yoshiro KITAHARA , Koji OHSUMI , Seiji KITAJIMA , Shimpei OGAWA
IPC: C07C335/20 , C07C335/16
CPC classification number: A61K31/17 , A61K31/277 , C07C335/16 , C07C335/20
Abstract: Sweetness receptor antagonists represented by formula (I): wherein each symbol is described herein, are useful for the prophylaxis or treatment of metabolic syndrome, diabetes, obesity and the like.
-
-
-
-
-
-
-
-